Physician profile
David Brown
NPI 1437670460
$26,758.06
in general payments reported to CMS, 2019-2025
8 companies · $1,635 in 2025
The $1,635 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,248 · 2023: $22K · 2024: $1,679 · 2025: $1,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $3,616 · Food and Beverage: $1,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $3,615.67 |
| Food and Beverage | $1,894.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,685.21 | 2023-2025 | |
| Medinc of Texas | $3,220.03 | 2022-2025 | |
| Stryker Corporation | $666.33 | 2023-2025 | Mako, Gamma, Pangea |
| Vericel Corporation | $115.43 | 2023 | Maci |
| Smith+Nephew, INC. | $38.90 | 2023-2024 | Healicoil, Firstpass, Bone Anchors With Arthroscopic Delivery System |
| Bioventus LLC | $17.32 | 2025 | Durolane |
| Nalu Medical, INC. | $14.84 | 2024 | Nalu Neurostimulation System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.